Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer PR Newswire HOLON, Israel, Feb. 15, 2024 HOLON, Israel , Feb. 15, 2024 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) , a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced the appointment of Michelle Mahler , M.D., as Chief Medical Officer, effective March 1, 2024 . Michelle will succeed Henry Adewoye , M.D., who is leaving Compugen to pursue other...